Institutional Ownership
Bridgebio Oncology Therapeut
CUSIP 107924102COM NEWBBOTQ1 2026
Institutional Holders
63
13F filers
Shares Held
56.58M
Aggregate institutional
Institutional Value
$501.97M
Q1 2026
Net New Holders
+12
19 new · 7 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions19
Increased20
Decreased11
Sold out7
Institutional Holders
63 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Cormorant Asset Management, LP | 17.88M | $160.01M | 0 | Held |
| 2 | Deerfield Management Company, L.P. | 4.89M | $43.72M | 0 | Held |
| 3 | Omega Fund Management, LLC | 3.29M | $29.44M | 0 | Held |
| 4 | Ecor1 Capital, LLC | 2.82M | $25.27M | 0 | Held |
| 5 | Alphabet Inc. | 2.82M | $25.27M | 0 | Held |
| 6 | Wellington Management Group LLP | 2.82M | $25.22M | −88.7K | Reduced |
| 7 | Enavate Sciences Gp, LLC | 2.63M | $23.51M | 0 | Held |
| 8 | Citadel Advisors LLC | 2.53M | $22.63M | −1.6K | Reduced |
| 9 | Novo Holdings A/S | 2.19M | $19.56M | +224.6K | Added |
| 10 | Blackrock, Inc. | 2.09M | $18.69M | +3.5K | Added |
53 more institutional holders on Premium
See every fund holding Bridgebio Oncology Therapeut, with full quarter-over-quarter share changes.
Unlock all holders